NCT05064631View on ClinicalTrials.gov

Bacterial Lysate In Preventing Asthma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

894

Participants

Timeline

Start Date

January 12, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

October 30, 2025

Conditions
Respiratory Tract InfectionsPediatric Respiratory DiseasesWheezing
Interventions
DRUG

Bacterial Lysate

Bacterial lysate medicines are made from bacterial cells that are broken down and are intended to stimulate the immune system.

Trial Locations (3)

E1 1FR

Royal London Hospital, London

SE5 9RS

King's College Hospital NHS Foundation Trust, London

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

All Listed Sponsors
collaborator

Queensland University of Technology

OTHER

lead

Queen Mary University of London

OTHER